↓ Skip to main content

Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care

Overview of attention for article published in British Journal of Clinical Pharmacology, May 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
10 news outlets
policy
1 policy source
twitter
28 tweeters
facebook
3 Facebook pages

Citations

dimensions_citation
82 Dimensions

Readers on

mendeley
123 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care
Published in
British Journal of Clinical Pharmacology, May 2014
DOI 10.1111/bcp.12292
Pubmed ID
Authors

Rupert A. Payne, Gary A. Abel, Anthony J. Avery, Stewart W. Mercer, Martin O. Roland

Abstract

Prescribing multiple medications is associated with various adverse outcomes, and polypharmacy is commonly considered suggestive of poor prescribing. Polypharmacy might thus be associated with unplanned hospitalization. We sought to test this assumption.

Twitter Demographics

The data shown below were collected from the profiles of 28 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 123 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 2%
France 1 <1%
Spain 1 <1%
India 1 <1%
Mexico 1 <1%
Unknown 116 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 23 19%
Student > Ph. D. Student 20 16%
Researcher 18 15%
Student > Postgraduate 15 12%
Student > Doctoral Student 11 9%
Other 35 28%
Unknown 1 <1%
Readers by discipline Count As %
Medicine and Dentistry 63 51%
Pharmacology, Toxicology and Pharmaceutical Science 16 13%
Unspecified 13 11%
Nursing and Health Professions 10 8%
Agricultural and Biological Sciences 4 3%
Other 16 13%
Unknown 1 <1%

Attention Score in Context

This research output has an Altmetric Attention Score of 98. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 December 2016.
All research outputs
#165,097
of 13,560,065 outputs
Outputs from British Journal of Clinical Pharmacology
#51
of 3,522 outputs
Outputs of similar age
#2,814
of 243,488 outputs
Outputs of similar age from British Journal of Clinical Pharmacology
#2
of 47 outputs
Altmetric has tracked 13,560,065 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,522 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.3. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 243,488 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.